Christopher C Goodnow

38PUBLICATIONS
342CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityLiquid biopsiesAutoimmunityMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Jan 16, 2026
Somatic deficiency of the human E3 ubiquitin ligase CBL in leukocytes impairs B cell but not T cell development and function.

Taja Vatovec, Anna-Lena Neehus, Katherine J L Jackson

|Dec 18, 2025
Convergent mutation trajectories convert functional self-tolerance in IGHV4-34 B cells to genetic tolerance encoded in the antibody.

Christopher J Jara, Sherin Zachariah, Katherine J L Jackson

|Dec 05, 2025
Reply to Bousdar et al.: Common inherited loss-of-function mutations in the innate sensor NOD2 contribute to exceptional immune response to cancer immunotherapy.

Megan B Barnet, Katherine J L Jackson, Christopher C Goodnow

|Jul 07, 2025
Common inherited loss-of-function mutations in the innate sensor NOD2 contribute to exceptional immune response to cancer immunotherapy.

Megan B Barnet, Katherine J L Jackson, Etienne Masle-Farquhar

|May 14, 2025
Expanded T cell clones with lymphoma driver somatic mutations accumulate in refractory celiac disease.

Mandeep Singh, Raymond H Y Louie, Jerome Samir

|Mar 21, 2025
Can autoimmune disease be cured by deep CD19+ cell depletion?

Dan Suan, John Moore, Christopher C Goodnow

Pageof 7